Theme 4: Cardiorespiratory Physiology Flashcards

1
Q

What is infant respiratory distress syndrome?

A
  • Occurs in infants born pre-maturely (before surfactant is produced)
  • It involves the lungs not filling properly and patchy collapse of parts of the lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do the lungs fill with in infant respiratory distress syndrome?

A

Hyaline membrane -> This is a mix of fibrin with cellular debris

This has led to the condition also being referred to as “hyaline membrane disease”.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Give some experimental evidence for the importance of surface tension in the lungs.

A

(Neergaard, 1929):

  • Plotted lung volume against pressure when inflating pig lungs with air and water
  • Found that the lungs inflated at a lower pressure when using water to fill them
  • He suggested that this was because the surface tension of the surfactant tends to pull the lung shut

(Mead, 1957):

  • Carried out a similar experiment to (Neergaard, 1929), except also looked at the deflation of the lungs
  • Found similar results and also noted that the lungs deflated more slowly than they inflated -> This property is called hysteresis
  • Hysteresis was not seen when filling with saline, which suggests that surface tension may also be responsible for hysteresis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the surface tension in a bubble (water-air interface)?

A

Around 70mN/m

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What equation can be used to deduce the pressure in an alveolus based on surface tension?

A

Laplace’s equation:

  • P = 2T/r
  • We can assume that tension is 70mN/m
  • Hence, the smaller the radius, the larger the pressure in the alveolus (making it susceptible to collapse)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the bubble model of alveolar (in)stability.

A
  • Assuming that the surface tension in each alveolus is equal, the smaller the radius of an alveolus, the larger the pressure inside will be (according to Laplace’s equation: P = 2T/r)
  • This means that air will move from the less inflated to the more inflated alveolus -> This will exacerbate the problem and potentially lead to collapse of some areas of the lung
  • Hence, the idea of a surfactant is desirable because it reduces surface tension. When the radius of an alveolus reduces, the surfactant becomes more concentrated, so it reduces the pressure inside and allows the alveoli to revert to normal size.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give some experimental evidence for the identification of surfactant.

A

(Brown, 1959):

  • Used a setup to study surface tension
  • Found that ground-up animal lung extract reduced the surface tension

(Brown, 1964):

  • Identified the main component of surfactant as dipalmitoyl phosphatidylcholine (DPPC)
  • The molecule has a polar head and a hydrophobic tail
  • It is mostly lipid and it disrupts the bonds between water molecules that drive surface tension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What cells produce surfactant?

A

Type II epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Draw a diagram to visualise the bubble model of alveolar (in)stability.

A

Note how the surfactant is on the INSIDE of the water layer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give experimental evidence FOR and AGAINST the bubble model of alveolar (in)stability.

A

FOR:

  • (Bastacky, 1995):
    • Produced a scanning electron microscopy image of rat lung
    • This showed a thin and continuous water layer lining the the alveolus
    • This is consistent with the bubble model of alveolar (in)stability

AGAINST:

  • (Dorrington, 2001):
    • Noted that the alveoli actually show a polygonal shape
    • In a polygon-shaped alveolus, a continuous thin liquid layer would be inherently unstable and it would be redistributed
    • However, this newly-redistributed fluid would ressemble what is seen in stable pulmonary oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe an alternative model to the bubble model of alveolar (in)stability. Give experimental evidence.

A
  • (Hill, 1990):
    • Noted that, not only could a spherical bubble of water not exist as the lining in a polygonal alveolus, but also that the surface tension would be pulling water from the alveolar walls into the lumen
    • Hills instead suggested a model where the surfactant is hydrophobic and exists on the walls of the alveolus, but not the corners
    • Therefore, fluid would only accumulate in the corners, helping keep the corners dry
    • Since the fluid would form convexly in the corners, the surface tension would also act outwards, pushing fluid into the alveolar walls and helping to keep the alveolar lumen dry

However, there is also evidence against this model:

  • (Weibel, 1979):
    • Produced images that show fluid accumulation in the corners of the alveoli BUT in a concave shape, not convex
  • (Bachofen, 1995):
    • Produced images of the alveoli
    • When extra fluid was added to the alveoli, they began to fill in a spherical shape
    • This was evidence against the idea of hydrophobic surfaces

Another model that was suggested was the active pumping of water out of the alveoli:

  • (Dorrington, 1995):
    • Suggested that surfactant exists only in the corners of the alveoli next to type II epithelial cells, which secrete surfactant and reduce surface tension
    • The rest of the lung is kept dry mostly by active absorption of water into the lung wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give experimental evidence for how water is actively absorbed in the alveoli.

A

(Crone, 1990):

  • Suggested a model with 3 types of protein on the epithelial cells:
    • Na+ channel (luminal side)
    • Na+/K+-exchanger (wall side)
    • Na+/glucose co-transporter
  • Measured fluid loss from the lung under experimental conditions
  • A control experiment with glucose showed greatest fluid loss, followed by the experiment with no glucose, followed by amiloride (Na+ channel blocker), followed by amiloride + no glucose
  • This confirmed the importance of glucose and the epithelial sodium channel in fluid absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Draw a summary of the main models of alveolar stability.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the clinical implications of surfactant?

A
  • Replacement of surfactant in infant respiratory distress syndrome
  • Some surfactant proteins may also have an immunological role (Nathan, 2016)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the triad of general anaesthesia?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe how general anaesthesia affects ventilation-respiratory control.

A
  • Diminishes pulmonary ventilation:
    • This includes reduced tidal volume and respiratory reserve
    • The amount of dead space may also be affected, which will affect CO2 control
    • Opiates produce deep sighing breaths
  • Increased physical obstruction of the airway due to reduced tone in the muscles that hold the airway open
  • Reduced diaphragm and intercostal muscle action leads to reduces functional residual capacity
  • Bronchodilation due to smooth muscle relaxation
  • V/Q mismatch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Draw a graph to show how general anaesthesia affects the relationship between PaCO2 and ventilation.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Draw a graph to show how general anaesthesia affects the relationship between PaO2 and ventilation.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe how general anaesthesia affects the cardiovascular system.

A
  • Reduced venous return -> Due to positive pressure ventilation, which makes it hard to get blood back into the lungs
  • Reduced mean arterial pressure -> Due to vasodilation
  • Reduced contractility of the heart
  • Slight tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How can the unwanted effects of general anaesthesia be counteracted?

A
  • Fluids
  • Vasopressors
  • Inotropes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Define shock.

A
  • Shock is defined as a state of cellular and tissue hypoxia due to either:
    • Reduced oxygen delivery
    • Increased oxygen consumption
    • Inadequate oxygen utilization
  • This most commonly occurs when there is circulatory failure manifested as hypotension (ie, reduced tissue perfusion); however, it is crucial to recognize that a patient in shock can present hypertensive, normotensive, or hypotensive.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are some physical signs of tissue hypoperfusion?

A
  • Brain -> Altered mental state
  • Skin -> Mottled, clammy
  • Kidney -> Oliguria
  • Heart -> Tachycardia
  • Blood -> Elevated lactate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Is lactate related to anoxia and oxygen delivery?

A

No, this is a bit of a myth. In reality, lactate is involved in many processes and it is not an indicator of anoxia and oxygen delivery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the 4 main types of shock?

A
  • Distributive
  • Hypovolaemic
  • Cardiogenic
  • Obstructive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are two causes of obstructive shock?

A
  • Pulmonary embolism
  • Tamponade

Overall, obstructive shock occurs when either:

  • The heart is working but there is a block to the outflow
  • Obstruction of the venous return to the heart
26
Q

Give experimental evidence describing fluid balance in the foetal lungs.

A

(Brown, 1983):

  • Studied the lung liquid volume and foetal plasma adrenaline levels in a foetal sheep
  • In the hours before birth, the lungs gradually increased in liquid volume, which suggests the alveolar epithelium plays a secretory role
  • Around birth, there there is a gradual drop in lung liquid volume, which is evidence of a shift towards the alveolar epithelium playing an absorptive role
  • This shift is associated with a sharp increase in adrenaline levels
27
Q

Why are the alveoli prone to fluid accumulation?

A
  • The pressure in the capillaries is at a pressure of around 10mmHg, while the alveolar space is at 0mmHg
  • Hence, there is an outward hydrostatic force driving the movement of water into the alveoli
28
Q

How do the lungs deal with fluid accumulation in the alveoli? Give experimental evidence.

A

There must be an active transport process to remove fluid from the alveoli.

(Basset, 1987):

  • Created a setup of an isolated rat lung connected to a circulation with an oxygenator and pump, with a perfusate in the circulation
  • Filled the rat lung with an instillate containing albumin, so that the albumin concentration could be used to measure absorption of the fluid into the circulation
  • Measured liquid absorption
  • Ouabain and amiloride reduced absorption
  • Repeated the experiment with a donor rat in the circuit and used a blood perfusate
  • Amiloride and no D-glucose reduced absorption
  • This led to the suggestion of this model

(Vejlstrup, 1994):

  • Created a setup where one rabbit lung was filled with an isosmotic instillate, allowing fluid absorption or secretion to be measured
  • Alveolar pressure was varied by altering the amount of fluid in the reservoir above the lung
  • Found that fluid uptake was relatively unaffected by alveolar pressures until higher alveolar pressures
  • When amiloride and phloridzin were used to block sodium transport, liquid uptake fell and was linearly related to the alveolar pressure -> At very low alveolar pressures, there was even some fluid secretion into the alveoli
  • The conclusion was that the lung is in a state in which it would fill up with liquid from the blood stream were it not for the presence of an active transport mechanism that ensures a movement of liquid in the opposite direction.
29
Q

Give experimental evidence for the role of active fluid clearance from the alveoli in pulmonary oedema.

A

(Verghese, 1999):

  • 65 patients were studied within 4h of intubation for severe hydrostatic pulmonary oedema (i.e. due to cardiac failure or fluid overload).
  • Measured alveolar protein content at least twice, to calculate the rate of alveolar fluid clearance (%/hr).
  • Divided the patients into those with intact alveolar clearance (>3%/hr) and those with impaired alveolar clearance (<3%/hr)
  • Found that the change in the A-a oxygen difference at 24 hours was greater in those with intact alveolar clearance
  • Hence, those with more vigorous alveolar sodium transport may recover more quickly from hydrostatic pulmonary oedema
  • However, limitations of the study include:
    • Methods for dichotomising patients
    • Potential for sampling errors with blind sampling
    • Potential for difference in absolute rates
30
Q

How can pulmonary oedema be treated with regards to fluid clearance? Give experimental evidence.

A

(Perkins, 2006) BALTI trial:

  • 40 patients with acute lung injury were followed for 7 days
    • 19 received IV salbutamol
    • 21 received placebo
  • There was a significant reduction in extravascular lung water in patients given salbutamol
  • This could be because salbutamol is a beta-agonist that stimulates the basolateral Na+/K+-ATPase and therefore drives sodium reabsorption from the alveolar space
  • However, around half of the patients in this study diet (in both groups)

(Smith, 2012) BALTI 2 trial:

  • Carried out a multi-centre trial of intravenous salbutamol in treatment of acute respiratory distress syndrome compared to placebo
  • Unfortunately, salbutamol led to increased mortality at 28 days of follow-up
  • Salbutamol was poorly tolerated due to tachycardia, arrhythmias and lactic acidosis.
31
Q

How does fluid clearance from the alveoli relate to HAPE? Give experimental evidence.

A
  • HAPE is classically thought to be due to stress failure in uneven HPV, but…
  • (Maggiorini, 2001):
    • Took invasive measurements with right heart catheters at 4559m to measure pulmonary arterial pressure and pulmonary capillary pressure
    • Took readings in HAPE and non-HAPE patients, as well as controls
    • HAPE was associated with increased pulmonary arterial AND capillary pressures, which would suggest that the oedema may be due to hydrostatic pressure gradients, not uneven HPV (which would instead cause some pulmonary capillary pressure readings to be very low and some to be very high)
    • This suggests that stimulation of active transport of fluid out of the alveolar space (e.g. using salbutamol) could help with HAPE
  • (Sartori, 2002):
    • 37 HAPE-susceptible subjects were taken to altitude for 48 h
    • 18 received salmeterol by inhalation; 19 received placebo
    • The salmetrol led to significantly reduced oedema, X-ray scores and Lake Louise scores
32
Q

How could fluid absorption from the alveolar space be altered in cardiogenic lung oedema? Give experimental evidence.

A
  • Cardiogenic lung oedema is classically thought to be a mechanical issue, where heart failure leads to increased pulmonary venous and capillary pressures, so that fluid is forced out
  • But recent experiments suggest that the situation may be more complex
  • (Solymosi, 2013):
    • Suggest that the hydrostatic pressure in the capillaries leads to NO release, which leads to downregulation of ENaC channels
    • This leads to a reversal of the electrical gradients across the membrane and hence reversal of Cl- transport
    • This drives fluid secretion into the alveolar space
33
Q

Draw a diagram to show the factors that contribute to breathlessness.

A
34
Q

Describe the relationship between breathlessness and lung function. Give experimental evidence.

A

(Herigstad, 2015):

  • Found no correlation between breathlessness and lung function
35
Q

Why is breathlessness clinically important? Give experimental evidence.

A
  • (CHEST, 2002):
    • Found that dyspnea (the sensation of breathlessness) is a better predictor of 5-year survival than airway obstruction in patients with COPD
  • (Abidov, 2005):
    • Found that dyspnea is a significant predictor of death in patient referred for cardiac stress testing
36
Q

What is the role of the periaqueductal grey in breathlessness expectation? Give experimental evidence.

A

(Farmer, 2014):

  • Stimulated different parts of the PAG
  • Found that stimulation of different parts led to bradypnea, tachypnea and other forms of breathing

(Faull, 2016 + 2017):

  • Did functional brain imaging of the brainstem and whole brain
  • Conditioned individuals to associate one shape with breathlessness and another shape with free breathing
  • Then put the individuals through a task FMRI and resting state FMRI
  • Found activity in one part of the brain associated with anticipation of breathlessness and activity in another associated with breathlessness itself
  • This led to disconnection between the PAG and some motor areas, and increased connection between the PAG and insula/amygdala
  • Breathlessness anxiety was found to be linearly correlated with increases in connectivity
37
Q

How does pulmonary rehabilitation for COPD work? Give experimental evidence.

A
  • Pulmonary rehabilitation involves exercise, social networking and education, after the doctor has done all they can for the patient
  • It produces clinical benefits in over 60% of patients
  • (Herigstad, 2017):
    • Found no difference in lung function, as measured by FEV1/FVC, after the pulmonary rehabilitation
    • Hence, the difference in clinical outcomes is unlikely to be due to physical changes in breathing
  • (Herigstad, 2016):
    • Showed COPD patients word cues for situations that would make them breathless while they were in an MRI scanner
    • Asked the patients to rate how breathless this situation would make them feel and how anxious this situation would make them feel
    • Repeated this process before and after pulmonary rehabilitation
    • The patients’ rating of how breathless each situation would make them feel did not change after the pulmonary rehabilitation, but their rating of how anxious it would make them decreased
    • These changes were associated with changes in brain activity in areas to do with expectation of breathlessness
38
Q

Can expectation of breathlessness be targeted pharmacologically? Give experimental evidence.

A

(Finnegan, unpublished):

  • Studied d-cycloserine, which is a partial NMDA agonist
  • This means that it enhances the cognitive learning effect
  • The hypothesis was that d-cycloserine would enhance the reversion of processing of breathlessness expectation towards normal after a pulmonary rehabilitation protocol
  • Did not find evidence of the effectiveness of d-cycloserine
39
Q

Are variations in physiology and health (in terms of breathlessness) related to distinct brain networks? Give experimental evidence.

A

(Luettich, unpublished):

  • Looked at over 19,000 individuals on the BioBank register, with around 2,500 of these having asthma and 250 having COPD
  • Looked at interoceptive brain areas using FMRI, so that it could be determined whether there were differences in connectivity between healthy and asthmatic patients
  • Also looked at 159 relevant non-imaging measures, such as pulse rate, smoking, etc.
  • Used canonical correlation analysis to test for associations between brain connectivity and the 159 non-imagin measures
  • Found 4 different modes of variation that explained the population
  • 2.5% of the variance was explained by the breathing parameter (mode 2)

(Finnegan, 2021):

  • Looked at the results of 23 different questionnaires filled in by patients with COPD
  • Peformed correlation analysis to see whether the different questionnaires related to each other
  • Found 4 subsections of questionnaires that produced similar results:
    • Mood
    • Illness burden (symptoms)
    • Ability (physical)
    • Ability (anticipated)
  • Using these 4 factors, the population could be split into a more impaired and less impaired group
  • These could be explained by difference in brain activity, suggesting that indeed differences are not explained by differences in pulmonary function, but by differences in cognitive factors

(Finnegan, unpublished):

  • Found that imaging and non-imaging measures alone were poor predictors of outcome in pulmonary rehabilitation
  • However, when these two factors are combined, they are a good predictor of outcome
40
Q

Give the main conclusions about breathlessness.

A
  • Expectation and emotion influence brain processes relating to perception of breathlessness
  • Pulmonary rehabilitation influences brain activity in areas associated with interoception
  • Data-driven approaches are starting to unpick complex brain-body interactions -> This could lead to stratification and personalised medicine
  • These approaches may include pharmacological enhancement of behavioural therapies
41
Q

What makes iron an effective redox molecule with a range of biological functions?

A
  • The redox potential of [Fe3+/Fe2+] is modulated by the complexing ligand.
  • This makes it suited for catalysing diverse biochemical reactions across a wide pH range.
42
Q

Give a summary of systemic iron homeostasis.

A
  • FPN = Ferroportin
  • Tf = Transferrin
  • Hepcidin inhibits iron uptake by ferroportin, promoting its storage instead
43
Q

Give a summary of cellular iron homeostasis.

A
  • Uptake -> Mostly via the transferrin receptor
  • Export -> Mostly via ferroportin
  • Storage -> Iron is stored within ferritin (which is like a cage)
  • Usage

When iron levels drop low, transferrin receptor expression is upregulated, and ferritin and ferroportin expression is downregulated.

When iron levels are too high, the opposite happens, which limits the formation of ROS.

44
Q

How is cellular iron sensed?

A

IRP1:

  • When iron is abundant, it contains iron-sulphur clusters, which enables it to acts in the TCA cycle
  • When iron is low, the conformation of the IRP1 changes, allowing it to bind RNA

IRP2:

  • When iron is abundant, it is degraded by FBXL5 (which only functions in the presence of iron and oxygen)
  • When iron is low, the IRP2 binds RNA

IRP1 and IRP2 inhibit translation of proteins involved in storage, usage and export of iron, while stabilising the translation of proteins involved in uptake of iron.

45
Q

What do IRP1 and IRP2 bind to?

A

Iron regulatory elements (IREs), which are hairpin loops in RNA.

46
Q

Give a summary of how iron deficiency affects the cardiorespiratory system.

A

Iron not only affects the system via causing anaemia, but also by direct effects on organs due to cellular iron deficiency.

47
Q

What are the effects of iron deficiency on the myocardium?

A
  1. Iron deficiency can lead to maladaptive anaemic heart failure (de novo)
  2. Iron deficiency is also a co-morbidity in existing heart failure (so it could worsen the heart failure)
48
Q

How does maladaptive anaemic heart failure occur? What is the cause? Give experimental evidence.

A
  • When anaemia occurs, there is an adaptive response that increases cardiac output to compensate
  • However, when hypertrophy occurs, this becomes maladaptive
  • Eventually, dilation happens, leading to reductions in cardiac output

This suggests that anaemia is the key driver:

(Lucille, 1990):

  • Found that patients with left ventricular hypertrophy in sickle cell anaemia had higher than predicted left ventricular mass and left ventricular cardiac output

(Park, 2020):

  • Found an association between haemoglobin and LV mass in healthy individuals (non-anaemic men and women) also

However, there is also evidence that iron deficiency itself is a driver:

(Kilp, 2013):

  • Drew survival curves for healthy patients and those with iron anaemia and/or iron deficiency
  • Iron deficiency without anaemia reduced survival almost as much as anaemia without iron deficiency
  • Iron deficiency and anaemia together reduced survival the most
  • This suggests that iron deficiency and anaemia may have a cumulative role in maladaptive anaemic heart failure
49
Q

What are the mechanisms that underpin the effects of iron deficiency on the myocardium?

A

There are two main categories of mechanism:

  • Haemodynamic (involving other organs)
  • Local (affecting the myocyte itself)
50
Q

Describe the haemodynamic mechanisms that underpin how iron deficiency affects the myocardium.

A
  • Severe chronic anaemia leads to peripheral vasodilation, which reduces blood pressure
  • This leads to catecholamine release and activation of the RAA axis, as well as natriuretic peptide release
  • This leads to decreased renal blood flow and glomerular filtration rate
  • Hence there is salt and water retention
  • This leads to increased plasma and extracellular volume, which increases work on the heart
  • This eventually leads to worsening heart failure, which in turn drives the anaemia again
51
Q

Describe the local mechanisms that underpin how iron deficiency affects the myocardium.

A
  • Haemoglobin and myoglobin synthesis are reduced due to the iron deficiency -> This means that there is not only impaired oxygen delivery but also impaired oxygen storage in the myocardium
  • Iron deficiency also leads to decreased activity in the Krebs cycle and ETC, since many of the enzymes require iron
  • Hence, there is energetic failure in the myocardium, which is a precursor to heart failure
  • Energetic failure may occur even when there is abundant oxygen because low iron leads to upregulated HIF -> This drives a shift towards glycolysis, which in the long-term is a maladaptive response
52
Q

How can we separate out the haemodynamic effects from the local effects of iron deficiency on the myocardium? Give experimental evidence.

A

What this question is asking is: to what degree are the effects on the myocardium due to systemic anaemia and to what degree are they due to local iron deficiency.

(Lakhal-Littleton, 2016):

  • Generated a mouse model where the cardiac myocytes are leaky to iron:
    • One mouse model was a hepcidin KO mouse
    • Another mouse model was one where the ferroportin is resistant to hepcidin
  • This lead to local iron deficiency without affecting systemic iron levels in the blood -> Hence, myocardial iron deficiency could be isolated
  • The systolic and diastolic left ventricular size decreased, and ejection fraction was decreased -> This led to fatal heart failure, leading to only around 20-30% survival by 52 weeks
  • Intravenous iron was able to prevent these consequences
  • The hepcidin KO mice showed signs of mitochondrial failure, unless intravenous iron was also supplied
  • Enzymes involved in energy-generation were reduced in the modified mice compared to controls and glycolysis was upregulated, unless intravenous iron was also supplied

Hence, animal models have shown that myocardial iron deficiency is sufficient to impair myocardial function in the absence of anaemia.

53
Q

Draw a summary of the effects of iron deficiency on the heart.

A
54
Q

Give some experimental evidence for the role of iron in normal pulmonary responses to hypoxia.

A

(Smith, 2008):

  • Exposed participants to 2 acute periods of hypoxia before and after an 8 hour period of prolonged hypoxia
  • Prior to this, they received an infusion of iron or saline
  • In the saline group, the second period of acute hypoxia resulted in a greater pulmonary hypertension than the first period
  • In the iron group, both periods of acute hypoxia resulted in a similar pulmonary hypertension (of same magnitude as the first period in the saline group)
  • Repeated this protocol without an prior infusion and replaced the 8 hour hypoxia with an 8 hour infusion of either saline or DFO (an iron chelator)
  • In the saline group, both periods of acute hypoxia resulted in a similar pulmonary hypertension
  • In the DFO group, the second period of acute hypoxia resulted in a greater pulmonary hypertension than the first period
  • Thus, the iron deficiency produced a similar effect to prolonged hypoxia

(Smith, 2009):

  • Studied participants ascending to an altitude of 4340m
  • Pulmonary arterial pressure rose within the first day
  • On the third day, some of the participants were given a placebo and some were given iron
  • The iron led to lower pulmonary arterial pressures over the next 4 days

(Frise, 2016):

  • Studied the pulmonary arterial pressure of patients receiving saline infusion during a period of hypoxia (over a period of hours)
  • Those with clinical iron deficiency showed greater pulmonary hypertension than the controls
  • When this was repeated with prior iron infusion instead of saline, the pulmonary pressure rose and then began to fall after 2 hours in both groups, with much lesser pulmonary hypertension in both groups
  • This could not be due to an effect on haemoglobin since the response is too fast
55
Q

Compare the effects of acute and chronic hypoxia on the pulmonary arteries. How does iron relate to this?

A
  • The effects of acute hypoxia are easily reversed and iron can help with this
  • Chronic hypoxia can lead to irreversible changes
  • Iron deficiency could be a contributor to the mechanisms that lead to chronic hypoxia-induced pulmonary arterial hypertension
56
Q

Give experimental evidence for the importance of iron deficiency in idiopathic pulmonary arterial hypertension.

A

(Rhodes, 2011):

  • Divided a population with PAH into those with a soluble transferrin receptor (sTfR) under 28.1 and those over 28.1
  • An sTfR over 28.1 is a sign of iron deficiency
  • The iron deficiency group showed lower cumulative survival over the next 7 years of follow-up

(Kramer, 2021):

  • Studied the use of intravenous iron supplementation in idiopathic PAH
  • The iron supplementation led to a reduction in PAH-associated hospitalisation
57
Q

What are the mechanisms that underpin the effects of iron on the pulmonary vasculature?

A
  • There cannot be haemodynamic mechanisms involved, since haemoglobin is not affected:
  • (Frise, 2016):
    • Studied the pulmonary arterial pressure of patients receiving saline infusion during a period of hypoxia (over a period of hours)
    • Those with clinical iron deficiency showed greater pulmonary hypertension than the controls
    • When this was repeated with prior iron infusion instead of saline, the pulmonary pressure rose and then began to fall after 2 hours in both groups, with much lesser pulmonary hypertension in both groups
    • This could not be due to an effect on haemoglobin since the response is too fast
    • There were also no other haemodynamic differences between groups: SpO2 and end-tidal pressures of O2 and CO2 were not different
  • (Smith, 2009):
    • Studied participants ascending to an altitude of 4340m
    • Pulmonary arterial pressure rose within the first day
    • On the third day, some of the participants were given a placebo and some were given iron
    • The iron led to lower pulmonary arterial pressures over the next 4 days
    • However, no differences in haematocrit were observed, so this cannot be the mechanism by which the iron produces the changes
  • Hence the changes are more likely to be due to local mechanisms:
  • (Lakhal-Littleton, 2019):
    • Produced iron deficiency in pulmonary arterial smooth muscle cells by producing tissue-specific hepcidin-resistant ferroportin receptors
    • This allowed intact systemic iron homeostasis
    • The iron deficient mice showed signs of increased muscularisation in the pulmonary arteries and raised right ventricular systolic pressures, which are a sign of PAH
    • The mice also showed signs of right heart failure, as measured by a decrease in right ventricular ejection fraction and an increase in right ventricular end systolic volume
    • Smooth muscle cells from the pulmonary arteries showed decreased total iron and ferritin iron -> This can be corrected with IV iron, which suggests that IV iron may be effective in patients because it enters SMCs
    • Intravenous iron also normalised right ventricular systolic pressure and partially reversed muscularisation
    • Smooth muscle cells also showed increased endothelin-1 (vasoconstrictor) production, leading to increased RVSP and RVESV, as well as decreased RVEF -> This could be reversed using an endothelin-1 receptor antagonist
    • Addition of ferric ammonium citrate (FAC) and hepcidin antimicrobial peptide (HAMP, a ferroportin antagonist) both produced lower ET-1 levels in PAH patients
    • Iron infusion also produced lower increases in ET-1 in response to hypoxia compared to saline infusion
58
Q

Why does iron deficiency lead to increased endothelin-1?

A
59
Q

Draw a summary of the effects of iron deficiency on the pulmonary circulation.

A
60
Q

Summarise the clinical implications of iron deficiency.

A
61
Q
A